Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology.
Thompson
D S
DS
Magee-Women's Hospital, University of Pittsburgh Cancer Institute, Western Psychiatric Institute and Clinic, PA 15213, USA.
D000275:Adjustment Disorders / Q000188:drug therapy* / Q000523:psychology; D000328:Adult; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy / Q000523:psychology; D001943:Breast Neoplasms / Q000523:psychology* / Q000628:therapy; D005260:Female; D005833:Genital Neoplasms, Female / Q000523:psychology* / Q000628:therapy; D006801:Humans; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D000078785:Mirtazapine; D009325:Nausea / Q000188:drug therapy* / Q000523:psychology; D016896:Treatment Outcome
D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine